Treace Medical Concepts

Treace Medical Concepts FCF Margin

The Free Cash Flow Margin of Treace Medical Concepts (TMCI) as of Nov 10, 2026 is -13.86 %. In the previous year, Free Cash Flow Margin was -23.29 % — a change of -40.47% (higher).

FCF Margin

-13.86 %

YoY

-40.47%

Last updated:

Free Cash Flow Margin of Treace Medical Concepts is 2025 -13.86 % . Free Cash Flow Margin of Treace Medical Concepts was 2024 -23.29 % . It decreases by -40.47% higher compared to the previous year.

The Treace Medical Concepts FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2019
-22.54 USD
Jan 1, 2020
-9.70 USD
Jan 1, 2021
-21.07 USD
Jan 1, 2022
-32.07 USD
Jan 1, 2023
-24.60 USD
Jan 1, 2024
-23.29 USD
Jan 1, 2025
-13.86 USD
The Treace Medical Concepts FCF Margin history
YEARFCF MarginYoY
-13.86 %-40.47%
-23.29 %-5.33%
-24.60 %-23.29%
-32.07 %+52.17%
-21.07 %+117.31%
-9.70 %-56.97%
-22.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Treace Medical Concepts Stock analysis

What does Treace Medical Concepts do? Treace Medical Concepts Inc is a US-based medical technology company that specializes in the development, manufacturing, and marketing of innovative orthopedic solutions. The company was founded in 2013 by John Treace and is headquartered in Palm Beach Gardens, Florida. The history of Treace Medical Concepts began with a simple idea. Founder John Treace was an orthopedic surgeon who often dealt with patients suffering from a condition called hallux valgus deformity, also known as bunions. The traditional treatment method for this problem was surgery, which was associated with high costs, long recovery times, and a high risk of complications. Treace recognized the need for a more effective and less invasive treatment method and decided to develop a solution. The result of these efforts was the Lapiplasty system, which was FDA approved in 2019. It is a novel procedure for correcting bunions, allowing for three-dimensional alignment of the affected joint. The procedure is quick, safe, and allows patients to walk normally just a few weeks after the surgery. Since the development of the Lapiplasty system, Treace Medical Concepts has expanded its business model and now offers a wide range of orthopedic solutions for various indications. The company has three main divisions: feet and ankles, hands and wrists, and shoulders and elbows. Each division offers a variety of products and solutions to treat a wide range of disorders and conditions. The most well-known products include the Lapiplasty system, as well as the KinetiSense system for motion analysis and the G-Force system for treating tennis elbow. Treace Medical Concepts aims not only to develop innovative products but also to ensure that these products are easily accessible to doctors and patients. The company has formed partnerships with leading medical institutions and distribution partners around the world to ensure that the products can be quickly and effectively used in clinical practice. The company is also dedicated to research and development, investing a significant portion of its revenue in developing new products and technologies. The company has already filed several patents and works closely with doctors and scientists to develop new solutions for a wide range of orthopedic problems. Overall, Treace Medical Concepts has the potential to change the way we treat orthopedic problems. The company has managed to be innovative while keeping the needs and requirements of doctors and patients in mind. With a strong corporate culture and dedicated leadership, Treace Medical Concepts has all the prerequisites to continue to succeed and improve the treatment of orthopedic problems worldwide. Treace Medical Concepts is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Treace Medical Concepts stock

Free Cash Flow Margin of Treace Medical Concepts is -13.86 % in 2025.

Free Cash Flow Margin of Treace Medical Concepts changed from -23.29 % to -13.86 %, representing a -40.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Treace Medical Concepts since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Treace Medical Concepts with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Treace Medical Concepts

All Key Metrics — Treace Medical Concepts